Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. CUVL

Market Cap: $300.05M

CL

Clinuvel Pharmaceuticals Ltd.

CUVL
NASDAQUSD
Purchase CUVL
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Executive

Peter Vaughan

Chief Financial Officer

Compensation
238,979
Emilie Rodenburger

Director of Global Clinical Affairs

Compensation
Compensation not disclosed
Linda Teng

Director of North American Operations

Compensation
Compensation not disclosed
Philippe Jacques Wolgen

CEO, MD & Director

Compensation
3,709,062
Azza Hamila

Head of Quality Assurance & Drug Safety

Compensation
Compensation not disclosed
Claire Newstead-Sinclair

Company Secretary

Compensation
Compensation not disclosed
Dennis J. Wright

Chief Scientific Officer

Compensation
260,216
Lachlan Hay

Chief Operations Officer

Compensation
389,214
Malcolm Bull

Head of Australian Operations & Investor Relations

Compensation
Compensation not disclosed